Skip to main content
SpringerLink
Log in

Blood Products

  • Chapter
Surgical Intensive Care Medicine

  • 185 Accesses

Abstract

Although progress has been made in ensuring the safety of transfusions, clinicians restrict the use of blood products to avoid exposing patients to allogeneic risk and conserve the supply (1). The potential alternatives, benefits, and risks associated with each transfusion are assessed before administration and, when possible, discussed with the patient. Table 1 shows the commonly administered blood components.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts—blood transfusion. N Engl J Med 1999; 340: 438–47.

    Article  PubMed  CAS  Google Scholar 

  2. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-frozen plasma, cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists. JAMA 1994; 271: 777–81.

    Article  Google Scholar 

  3. Corwin HL, Parsonnet KC, Gettinger A. RBC transfusion in the ICU: Is there a reason? Chest 1995; 108: 767–71.

    Google Scholar 

  4. Greenburg AG. A physiologic basis for red blood cell transfusion decisions. Am J Surg 1995; 170 (6A Suppl): 44S - 48S.

    Article  PubMed  CAS  Google Scholar 

  5. Hsia CC. Respiratory function of hemoglobin. N Engl J Med 1998; 338: 239–47.

    Article  PubMed  CAS  Google Scholar 

  6. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269: 3024–9.

    Article  PubMed  CAS  Google Scholar 

  7. Stehling L, Simon TL. The red blood cell transfusion trigger. Physiology and clinical studies. Arch Pathol Lab Med 1994; 118: 429–34.

    PubMed  CAS  Google Scholar 

  8. Welch HG, Meehan KR, Goodnough LT. Prudent strategies for elective red blood cell transfusion. Ann Intern Med 1992; 116: 393–402.

    PubMed  CAS  Google Scholar 

  9. Simon TL, Alverson DC, AuBuchon J, Cooper ES, DeChristopher PJ, Glenn GC, Gould SA, Harrison CR, Milam JD, Moise KJ Jr, Rodwig FR Jr, Sherman LA, Shulman IA, Stehling L. Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 1998; 122: 130–8.

    PubMed  CAS  Google Scholar 

  10. Weiskopf RB, Viele MK, Feiner J, Kelley S, Lieberman J, Noorani M, Leung JM, Fisher DM, Murray WR, Toy P, Moore MA. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998; 279: 217–21.

    Article  PubMed  CAS  Google Scholar 

  11. Mathru M, Kleinman B, Blakeman B, Sullivan H, Kumar P, Dries DJ. Myocardial metabolism and adaptation during extreme hemodilution in humans after coronary revascularization. Crit Care Med 1992; 20: 1420–5.

    Article  PubMed  CAS  Google Scholar 

  12. Hebert PC, Wells G, Tweeddale M, Martin C, Marshall J, Pham B, Blajchman M, Schweitzer I, Pagliarello G. Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med 1997; 155: 1618–23.

    Article  PubMed  CAS  Google Scholar 

  13. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409–17.

    Google Scholar 

  14. Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG. High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. J Trauma 1998; 44: 361–7.

    Article  PubMed  CAS  Google Scholar 

  15. Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Melot C, Vincent JL. Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997; 23: 159–62.

    Article  PubMed  CAS  Google Scholar 

  16. Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ. Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med 1999; 27: 2346–50.

    Article  PubMed  CAS  Google Scholar 

  17. Rutherford CJ, Schneider TJ, Dempsey H, Kirn DH, Brugnara C, Goldberg MA. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response. Am J Med 1994; 96: 13945.

    Article  Google Scholar 

  18. Tielemans CL, Lenclud CM, Wens R, Collart FE, Dratwa M. Critical role of iron overload in the increased susceptibility of haemodialysis patients to bacterial infections. Beneficial effects of desferrioxamine. Nephrol Dial Transplant 1989; 4: 883–7.

    PubMed  CAS  Google Scholar 

  19. Patruta SI, Edlinger R, Sunder-Plassmann G, Horl WH. Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. J Am Soc Nephrol 1998; 9: 655–63.

    PubMed  CAS  Google Scholar 

  20. Muench KH. Hemochromatosis and infection: alcohol and iron, oysters and sepsis. Am J Med 1989; 87: 40N - 43N.

    PubMed  CAS  Google Scholar 

  21. Oppenheimer SJ. Iron and infection: the clinical evidence. Acta Paediatr Scand Suppl 1989; 361: 53–62.

    PubMed  CAS  Google Scholar 

  22. Sarraf-Yazdi S, Sheng H, Grocott HP, Bart RD, Pearlstein RD, Steffen RP, Warner DS. Effects of RSR13, a synthetic allosteric modifier of hemoglobin, alone and in combination with dizocilpine, on outcome from transient focal cerebral ischemia in the rat. Brain Res 1999; 826: 172–80.

    Article  PubMed  CAS  Google Scholar 

  23. Sprung J, Mackenzie CF, Bamas GM, Williams JE, Parr M, Christenson RH, Hoff BH, Sakamoto R, Kramer A, Lottes M. Oxygen transport and cardiovascular effects of resuscitation from severe hemorrhagic shock using hemoglobin solutions. Crit Care Med 1995; 23: 1540–53.

    Article  PubMed  CAS  Google Scholar 

  24. Newman BH, Shafer AW, Saeed SM. Patterns of use of group O, Rh-negative red cells in a large metropolitan area and an action plan to control utilization. Transfusion 1996; 36: 209–12.

    Article  PubMed  Google Scholar 

  25. Infectious disease testing for blood transfusions. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions. JAMA 1995; 274: 1374–9.

    Article  Google Scholar 

  26. Klein HG. Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology 1999; 91: 861–5.

    Article  PubMed  CAS  Google Scholar 

  27. Francis DM. Relationship between blood transfusion and tumour behaviour. Br J Surg 1991; 78: 1420–8.

    Article  PubMed  CAS  Google Scholar 

  28. Ownby HE, Kong F, Watanabe K, Tu Y, Nass CC. Analysis of donor return behavior. Retrovirus Epidemiology Donor Study. Transfusion 1999; 39: 1128–35.

    Article  PubMed  CAS  Google Scholar 

  29. Silberman S. Platelets: preparations, transfusion, modifications, and substitutes. Arch Pathol Lab Med 1999; 123: 889–94.

    PubMed  CAS  Google Scholar 

  30. Neff PE, Kelly KP, Tobias JD. Septic shock from the administration of a bacterially contaminated platelet transfusion. South Med J 1999; 92: 1194–8.

    Article  PubMed  CAS  Google Scholar 

  31. Chiu EK, Yuen KY, Lie AK, Liang R, Lau YL, Lee AC, Kwong YL, Wong S, Ng MH, Chan TK. A prospective study of symptomatic bacteremia following platelet transfusion and of its management. Transfusion 1994; 34: 950–4.

    Article  PubMed  CAS  Google Scholar 

  32. Rinder HM, Arbini AA, Snyder EL. Optimal dosing and triggers for prophylactic use of platelet transfusions. Cuff Opin Hematol 1999; 6: 437–41.

    Article  CAS  Google Scholar 

  33. Koyanagi T, Kyo S, Hirooka E, Koyama I, Omoto R. Redo without transfusion in a patient with idiopathic thrombocytopenic purpura. Ann Thorac Surg 2000; 69: 1261–3.

    Article  PubMed  CAS  Google Scholar 

  34. Engelfriet CP, Reesink HW, Blajchman MA, Muylle L, Kjeldsen-Kragh J, Kekomaki R, Yomtovian R, Hocker P, Stiegler G, Klein HG, Soldan K, Barbara J, Slopecki A, Robinson A, Seyfried H. Bacterial contamination of blood components. Vox Sang 2000; 78: 59–67.

    Article  PubMed  CAS  Google Scholar 

  35. Guideline for the use of fresh-frozen plasma. Medical Directors Advisory Committee, National Blood Transfusion Council. S Afr Med J 1998; 88: 1344–7.

    Google Scholar 

  36. Humphries JE. Transfusion therapy in acquired coagulopathies. Hematol Oncol Clin North Am 1994; 8: 1181–201.

    PubMed  CAS  Google Scholar 

  37. Rose M, Rowe JM, Eldor A. The changing course of thrombotic thrombocytopenic purpura and modem therapy. Blood Rev 1993; 7: 94–103.

    Article  PubMed  CAS  Google Scholar 

  38. Klein HG, Dodd RY, Dzik WH, Luban NL, Ness PM, Pisciotto P, Schiff PD, Snyder EL. Current status of solvent/detergent-treated frozen plasma. Transfusion 1998; 38: 102–7.

    Article  PubMed  CAS  Google Scholar 

  39. Williams EF. Current transfusion therapy: indications for basic components. Clin Lab Sci 1994; 7: 219–24.

    PubMed  CAS  Google Scholar 

  40. Adkins D, Ali S, Despotis G, Dynis M, Goodnough LT. Granulocyte collection efficiency and yield are enhanced by the use of a higher interface offset during apheresis of donors given granulocyte-colony-stimulating factor. Transfusion 1998; 38: 557–64.

    Article  PubMed  CAS  Google Scholar 

  41. Rieger A, Philippi W, Spies C, Eyrich K. Safe and normothermic massive transfusions by modification of an infusion warming and pressure device. J Trauma 1995; 39: 686–8.

    Article  PubMed  CAS  Google Scholar 

  42. Cinat ME, Wallace WC, Nastanski F, West J, Sloan S, Ocariz J, Wilson SE. Improved survival following massive transfusion in patients who have undergone trauma. Arch Surg 1999; 134: 964–70.

    Article  PubMed  CAS  Google Scholar 

  43. Cosgriff N, Moore EE, Sauaia A, Kenny-Moynihan M, Burch JM, Galloway B. Predicting life- threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma 1997; 42: 857–62.

    Article  PubMed  CAS  Google Scholar 

  44. Jeter EK, Spivey MA. Noninfectious complications of blood transfusion. Hematol Oncol Clin North Am 1995; 9: 187–204.

    PubMed  CAS  Google Scholar 

  45. Linden JV, Paul B, Dressler KP. A report of 104 transfusion errors in New York State. Transfusion 1992; 32: 601–6.

    Article  PubMed  CAS  Google Scholar 

  46. von Zabern I, Ehlers M, Grunwald U, Mauermann K, Greinacher A. Release of mediators of systemic inflammatory response syndrome in the course of a severe delayed hemolytic transfusion reaction caused by anti-D. Transfusion 1998; 38: 459–68.

    Google Scholar 

  47. Gorman TE, Julius CJ, Barth RF, Ng A, Kennedy MS, Prior TW, Allen J, Lasky LC. Transfusion- associated graft-vs-host disease. A fatal case caused by blood from an unrelated HLA homozygous donor. Am J Clin Pathol 2000; 113: 732–7.

    Article  PubMed  CAS  Google Scholar 

  48. Ramsey G. The pathophysiology and organ-specific consequences of severe transfusion reactions. New Horiz 1994; 2: 575–81.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Massachusetts General Hospital, Boston, MA, 02114, USA

    William D. Hoffman M.D.

Authors
  1. William D. Hoffman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Surgical Intensive Care Unit, Department of Surgical Critical Care, Lahey Clinic Medical Center, Burlington, MA, USA

    John Merritt O’Donnell M.D. (Director, Chairman) (Director, Chairman)

  2. Department of Surgical Critical Care, Lahey Clinic Medical Center, Burlington, MA, USA

    Flávio Eduardo Nácul M.D. (Senior Fellow) (Senior Fellow)

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hoffman, W.D. (2001). Blood Products. In: O’Donnell, J.M., Nácul, F.E. (eds) Surgical Intensive Care Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6645-5_32

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6645-5_32

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6647-9

  • Online ISBN: 978-1-4757-6645-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation